Ho Carole bought DNLI
August 5, 2025 · Form 4 insider transaction
Ho Carole bought 44,655 shares of Denali Therapeutics Inc. at $0.68 per share, a transaction worth $30.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
44,655
Price
$0.68
Total value
$30.4K
InsiderHo Carole
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 5, 2025
Filing dateAugust 7, 2025
Shares owned after220,328
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 134,030 Unvested RSUs.